COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implication

COL1A1-PDGFB gene fusion associated uterine sarcoma, so called dermatofibrosarcoma-like tumor, a recently reported entity in the uterine corpus, morphologically appears as high grade sarcoma with some features of dermatofibrosarcoma. So far only one other case has been reported in the uterine corpus...

Full description

Bibliographic Details
Main Authors: Samuel L. Grindstaff, Jessica DiSilvestro, Katrine Hansen, Paul DiSilvestro, C. James Sung, M. Ruhul Quddus
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:Gynecologic Oncology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578919301122
_version_ 1811279898398949376
author Samuel L. Grindstaff
Jessica DiSilvestro
Katrine Hansen
Paul DiSilvestro
C. James Sung
M. Ruhul Quddus
author_facet Samuel L. Grindstaff
Jessica DiSilvestro
Katrine Hansen
Paul DiSilvestro
C. James Sung
M. Ruhul Quddus
author_sort Samuel L. Grindstaff
collection DOAJ
description COL1A1-PDGFB gene fusion associated uterine sarcoma, so called dermatofibrosarcoma-like tumor, a recently reported entity in the uterine corpus, morphologically appears as high grade sarcoma with some features of dermatofibrosarcoma. So far only one other case has been reported in the uterine corpus and two in the uterine cervix. Identification of this gene fusion allows greater choice of targeted therapy in these patients. All the reported cases in the mullerian system are found to be CD34 positive by immunohistochemistry, a commonly used antibody in most immunohistochemistry laboratories. We would, therefore, propose routine CD34 immunohistochemical staining in all high grade uterine sarcomas which have failed other common immunohistochemical markers. Keywords: Uterine sarcoma, Dermatofibrosarcoma protuberans (DFSP), COL1A1-PDGFB fusion, Imatinib
first_indexed 2024-04-13T01:04:08Z
format Article
id doaj.art-395e1e55c9fb43d7839993e372e69d58
institution Directory Open Access Journal
issn 2352-5789
language English
last_indexed 2024-04-13T01:04:08Z
publishDate 2020-02-01
publisher Elsevier
record_format Article
series Gynecologic Oncology Reports
spelling doaj.art-395e1e55c9fb43d7839993e372e69d582022-12-22T03:09:24ZengElsevierGynecologic Oncology Reports2352-57892020-02-0131COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implicationSamuel L. Grindstaff0Jessica DiSilvestro1Katrine Hansen2Paul DiSilvestro3C. James Sung4M. Ruhul Quddus5Department of Pathology and Laboratory Medicine, Women & Infants Hospital, Alpert Medical School of Brown University, Providence, RI, USA; Corresponding author.Program in Women’s Oncology, Women & Infants Hospital, Alpert Medical School of Brown University, Providence, RI, USADepartment of Pathology and Laboratory Medicine, Women & Infants Hospital, Alpert Medical School of Brown University, Providence, RI, USAProgram in Women’s Oncology, Women & Infants Hospital, Alpert Medical School of Brown University, Providence, RI, USADepartment of Pathology and Laboratory Medicine, Women & Infants Hospital, Alpert Medical School of Brown University, Providence, RI, USADepartment of Pathology and Laboratory Medicine, Women & Infants Hospital, Alpert Medical School of Brown University, Providence, RI, USACOL1A1-PDGFB gene fusion associated uterine sarcoma, so called dermatofibrosarcoma-like tumor, a recently reported entity in the uterine corpus, morphologically appears as high grade sarcoma with some features of dermatofibrosarcoma. So far only one other case has been reported in the uterine corpus and two in the uterine cervix. Identification of this gene fusion allows greater choice of targeted therapy in these patients. All the reported cases in the mullerian system are found to be CD34 positive by immunohistochemistry, a commonly used antibody in most immunohistochemistry laboratories. We would, therefore, propose routine CD34 immunohistochemical staining in all high grade uterine sarcomas which have failed other common immunohistochemical markers. Keywords: Uterine sarcoma, Dermatofibrosarcoma protuberans (DFSP), COL1A1-PDGFB fusion, Imatinibhttp://www.sciencedirect.com/science/article/pii/S2352578919301122
spellingShingle Samuel L. Grindstaff
Jessica DiSilvestro
Katrine Hansen
Paul DiSilvestro
C. James Sung
M. Ruhul Quddus
COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implication
Gynecologic Oncology Reports
title COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implication
title_full COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implication
title_fullStr COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implication
title_full_unstemmed COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implication
title_short COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implication
title_sort col1a1 pdgfb fusion uterine fibrosarcoma a case report with treatment implication
url http://www.sciencedirect.com/science/article/pii/S2352578919301122
work_keys_str_mv AT samuellgrindstaff col1a1pdgfbfusionuterinefibrosarcomaacasereportwithtreatmentimplication
AT jessicadisilvestro col1a1pdgfbfusionuterinefibrosarcomaacasereportwithtreatmentimplication
AT katrinehansen col1a1pdgfbfusionuterinefibrosarcomaacasereportwithtreatmentimplication
AT pauldisilvestro col1a1pdgfbfusionuterinefibrosarcomaacasereportwithtreatmentimplication
AT cjamessung col1a1pdgfbfusionuterinefibrosarcomaacasereportwithtreatmentimplication
AT mruhulquddus col1a1pdgfbfusionuterinefibrosarcomaacasereportwithtreatmentimplication